Revolutionizing frontline care

Personalized medicine
needs the full picture.

We build the infrastructure that supplies it: one pipeline that encodes a patient's daily life, the exam and the conversation, reasons over all of it, and hands the clinic the output.

Clinical trials
2
Institutions signed
Pharmacy partnerships
28
From our prior venture
Examination devices
3
Built, awaiting certification
Ontology, live today
532k
SNOMED CT concepts

One pipeline, three stages.

Sold to clinics and pharmacies as a single package. Each stage feeds the next, and the last feeds the first.

01

Aggregate

The data aggregation engine

A patient-facing portal that learns daily life from the sources a person already has, adds their past records, and encodes all of it into SNOMED CT before the appointment starts.

Status
Launches September 2026
02

Reason

The CDSS core

Reasons over the aggregated history, live vitals from our own examination devices, and the consultation itself, with prescribing guidance built in.

Status
MVP targeted 2027
03

Output

What the clinic gets back

Differentials ranked against the patient’s own history, documentation written into the provider’s existing systems, and prescribing that cuts stock wastage. Insights feed back to stage one.

Status
Clinics in 2027

Every stage reads and writes the same terminology: SNOMED CT, ICD-11, LOINC and HPO. The graph is live and explorable today.

Explore the graph

One patient-centred care loop.

Daily life goes in. A fuller history reaches your clinician. The plan comes back as habits you can keep, and the next appointment starts further ahead than the last.

  1. 1

    Live Patient portal

    Connectors and conversation become one living, SNOMED-encoded bio-psycho-social history, ready before the appointment starts.

  2. 2

    Reason Auracare CDSS

    Shared history, acute vitals, transcription, labs and records reasoned over together. It asks only what is worth asking.

  3. 3

    Decide Auracare CDSS

    A lifestyle plan, a referral or a guideline-aligned medication package, matched to the clinician’s jurisdiction. Their judgement makes the call.

  4. 4

    Return Patient portal

    Advice returns to the portal as reminders tuned to how the person actually lives, and the portal watches the follow-through.

One continuous loop: the picture keeps getting richer.

A learned model proposes.
A symbolic layer disposes.

Every signal is encoded onto the terminology medicine already agrees on, so every answer traces back to a named source rather than to a model's confidence. A clinician can follow the reasoning back to those sources and stay in the loop.

SNOMED CT concepts
532k
Relationships mapped
1.3M
ICD-11 categories
32k
LOINC lab codes
217k

The graph is live and explorable today. The reasoning engine that acts on it is in development.

We began at the front line of care.
We built on every lesson it taught us.

Auracare started with twenty-eight pharmacies and an NHS API we could not reach until 2028.

  1. 2025

    Auracare is founded

    We began inside UK primary care, building NHS data tooling and a pharmacy prescribing product with automated clinical notes.

  2. 2025 → early 2026

    28 pharmacy partnerships

    Our prior venture reached twenty-eight UK pharmacies, including a regional director, and showed us the structural gaps inside a public health system first-hand.

  3. Early 2026

    We hit the wall

    Our aggregation product was built, but the NHS gates its API behind contracts that do not renew until 2028. We shelved that line and kept the foundation.

  4. May 2026

    We pivot to the pipeline

    A new direction: a clinical decision support system for providers, with a patient-facing portal as the first stage of the same pipeline.

    The pivot
  5. Jul 2026

    The data aggregation engine

    Stage one reached its first build: the patient portal, aggregating daily life and encoding it into SNOMED CT.

  6. Sep 2026 We are here

    The portal launches

    The patient portal opens to the public, and the ontology goes live for anyone to explore.

  7. Dec 2026

    First clinical trial

    Trials begin with EC Healthcare in Hong Kong, while our stethoscope, BP monitor and otoscope head toward certification.

  8. Feb 2027

    Chinese Academy of Sciences trial

    A second trial begins with the CAS, and the CDSS moves toward its MVP.

  9. 2027

    Clinics

    With the devices certified, the full pipeline rolls out to providers, China-forward via the Greater Bay Area.

Early days, real momentum.

Funding, partnerships and clinical pilots already in place, before this round.

UK pharmacy partnerships, prior venture
28
UK government funding awarded
$134k
Angel investment, Hong Kong
$400k
Founders Factory Healthcare resources
~$400k
Clinical trials signed in Hong Kong and China
2
Hardware OEM partnerships in China
2

Research pedigree, and a route to trials

  • Imperial College London
  • UC Berkeley
  • Chinese Academy of Sciences

Imperial College London & UC Berkeley

Founded out of two of the world’s top-ranked programmes, medicine at Imperial and computer science at Berkeley, pairing frontline clinical training with deep engineering from day one.

Chinese Academy of Sciences

A partnership agreed with the CAS gives us access to clinical trials and the resources to run them, our route into the clinic.

A small, founder-led team.

Spanning London, Hong Kong and San Francisco.

  • Portrait of Tanush Pandey

    Tanush Pandey

    Co-founder · CEO & CMO

    Co-founder and our London presence, reading Medicine at Imperial College London. Leads clinical strategy, safety and the medical evidence behind Auracare.

  • Portrait of Stephen Okita

    Stephen Okita

    Co-founder · CTO

    Co-founder, computer science at UC Berkeley. Sets the technical architecture and product direction, and leads business relations in San Francisco.

  • Portrait of Hinlun Chen

    Hinlun Chen

    Co-founder · COO

    Co-founder, PPE at LSE, and runs an OEM with two factories. Leads operations and partnerships, and business relations in Hong Kong and China.

  • Portrait of Julius Chu

    Julius Chu

    CPO

    Computer science at NYU. Leads product: the design system, the patient experience, and how the stages of the pipeline fit together.

  • Portrait of Ahnaf Kabir

    Ahnaf Kabir

    CISO

    Former software lead at Slate and previously co-founder of a medtech company bringing aural health to the home. Manages security operations, technical infrastructure and backend engineering.

  • Portrait of Karam Elradie

    Karam Elradie

    Head of ML

    Leads machine learning: the neuro-symbolic core and graph models behind our reasoning.

Talk to us.

We are raising our seed round, and we are looking for clinical partners as the CDSS moves toward its first trials.

Investors

One founder replies directly, depending on where you invest from.

See the investor page

Clinical partners

Hospitals, practices and pharmacies working on decision support.

Write to our clinical team

The patient portal, the first stage of the pipeline, launches in September 2026. Join the waitlist.

Our patient portal is a general-wellness product, not a medical device. It does not diagnose, treat, cure or prevent any disease. Always seek professional medical advice for health concerns.